Back
Constellation Brands 10K Form
Sell
45
STZ
Constellation Brands
Last Price:
$186.64
Seasonality Move:
5.86%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-07-03 | 10Q | STZ/Constellation Brands Quarterly |
2024-04-23 | 10K | STZ/Constellation Brands Annual |
2024-01-05 | 10Q | STZ/Constellation Brands Quarterly |
2023-10-05 | 10Q | STZ/Constellation Brands Quarterly |
2023-06-30 | 10Q | STZ/Constellation Brands Quarterly |
2023-04-20 | 10K | STZ/Constellation Brands Annual |
Receive STZ News And Ratings
See the #1 stock for the next 7 days that we like better than STZ
STZ Financial Statistics
Sales & Book Value
Annual Sales: | $10.2B |
---|---|
Cash Flow: | $312.1M |
Price / Cash Flow: | 17.5 |
Annual Sales: | $38.08 |
Price / Book: | 4.9 |
Profitability
EPS (TTM): | -0.51000 |
---|---|
Net Income (TTM): | $-81.4M |
Gross Margin: | $5.3B |
Return on Equity: | -0.93% |
Return on Assets: | -0.34% |
Constellation Brands Earnings Forecast
Key Constellation Brands Financial Ratios
-
The Gross Profit Margin over the past 42 years for STZ is 52.06%.
-
The Selling, General & Administrative Expenses for STZ have been equal to 19.10% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of STZ is -0.80% of Total Revenues.
-
Per Share Earnings over the last 42 years have been positive in 29 years.
Constellation Brands Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Beverages |
Sector: | Consumer Staples |
Current Symbol: | STZ |
CUSIP: | 21036P |
Website: | cbrands.com |
Debt
Debt-to-Equity Ratio: | 1.67 |
---|---|
Current Ratio: | 0.92 |
Quick Ratio: | 0.2 |
Price-to-Earnings
Trailing P/E Ratio: | 19.53 |
---|---|
Forward P/E Ratio: | 13.35 |
STZ Technical Analysis vs Fundamental Analysis
Sell
45
Constellation Brands (STZ)
is a Sell
Is Constellation Brands a Buy or a Sell?
-
Constellation Brands stock is rated a SellThe current Constellation Brands [STZ] share price is $186.63. The Score for STZ is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.